For: | Ince V, Sahin TT, Akbulut S, Yilmaz S. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World J Clin Cases 2022; 10(29): 10413-10427 [PMID: PMC9602233 DOI: 10.12998/wjcc.v10.i29.10413] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i29/10413.htm |
Number | Citing Articles |
1 |
Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroki Teraoku, Yuhei Waki, Chiharu Nakasu, Mitsuo Shimada. Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-022-01892-6
|
2 |
Julian K. Horwitz, Vatche G. Agopian. Indication of Liver Transplant for HCC: Current Status and Future Directions. Current Hepatology Reports 2024; 23(1): 185 doi: 10.1007/s11901-024-00641-y
|
3 |
Jinli Zheng, Xiaozhen Wei, Ning Wang, Xingyu Pu, Jiayin Yang, Li Jiang. A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-01967-y
|
4 |
金连 李. Advances in Diagnosis and Treatment of Hepatocellular Carcinoma. Advances in Clinical Medicine 2024; 14(07): 738 doi: 10.12677/acm.2024.1472075
|
5 |
Nam Hoang Duc. Liver Transplantation - Challenges and Opportunities. 2024; doi: 10.5772/intechopen.1004265
|
6 |
Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02236-8
|
7 |
Ertugrul Karabulut, Sami Akbulut, Emine Turkmen Samdanci, Ayse Nur Akatli, Ahmed Elsarawy, Zeynep Kucukakcali, Zeki Ogut, Adem Tuncer, Volkan Ince, Sezai Yilmaz. Are Ki-67 and Procalcitonin Expression Levels Useful in Predicting the Biological Behavior of Hepatocellular Carcinoma After Liver Transplantation?. Journal of Clinical Medicine 2024; 14(1): 144 doi: 10.3390/jcm14010144
|
8 |
Takashi Kokudo, Norihiro Kokudo. Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria. Cancers 2025; 17(3): 507 doi: 10.3390/cancers17030507
|
9 |
Amjad Khalil, Alberto Quaglia, Pierre Gélat, Nader Saffari, Hassan Rashidi, Brian Davidson. New Developments and Challenges in Liver Transplantation. Journal of Clinical Medicine 2023; 12(17): 5586 doi: 10.3390/jcm12175586
|
10 |
Victor Lopez-Lopez, Kohei Miura, Christoph Kuemmerli, Antonio Capel, Dilmurodjon Eshmuminov, David Ferreras, Alberto Baroja-Mazo, Pedro Cascales-Campos, María Isabel Jiménez-Mascuñán, José Antonio Pons, Maria Isabel Castellon, Francisco Sánchez-Bueno, Ricardo Robles-Campos, Pablo Ramírez. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis. Cancers 2023; 15(7): 2122 doi: 10.3390/cancers15072122
|
11 |
Xinyu He, Shengjun Xu, Linsong Tang, Sunbin Ling, Xuyong Wei, Xiao Xu. Insights into the history and tendency of liver transplantation for liver cancer: A bibliometric-based visual analysis. International Journal of Surgery 2023; doi: 10.1097/JS9.0000000000000806
|
12 |
Leonardo Lorente, Sergio T Rodriguez, Pablo Sanz, Agustín F González-Rivero, Antonia Pérez-Cejas, Javier Padilla, Dácil Díaz, Antonio González, María M Martín, Alejandro Jiménez, Purificación Cerro, Julián Portero, Manuel A Barrera. Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations . World Journal of Clinical Cases 2023; 11(8): 1753-1760 doi: 10.12998/wjcc.v11.i8.1753
Abstract(586) |
Core Tip(464) |
Full Article(HTML)(1326)
|
Full Article (PDF)-1008K(141)
|
Full Article (Word)-308K(39)
|
Audio-126K(5)
|
Peer-Review Report-459K(61)
|
Answering Reviewers-161K(65)
|
Times Cited (0)
|
Total Visits (5331)
|
Open
|